Seach Medical Financials

SEMG Stock  ILA 270.70  10.70  3.80%   
We advise to exercise Seach Medical fundamental analysis to see if markets are presently undervaluing or overvaluing the firm. In other words, this technique allows you to confirm available indicators of Seach Medical Group as well as the relationship between them. We were able to analyze twenty-five available drivers for Seach Medical Group, which can be compared to its competition. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Seach Medical to be traded at 259.87 in 90 days.
  
Understanding current and past Seach Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Seach Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Seach Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Seach Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Seach Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Seach Medical's management manipulating its earnings.

Seach Medical Stock Summary

Seach Medical competes with Nextgen, Gencell, Bonus Biogroup, Intelicanna, and Aerodrome. Seach Medical Group Ltd. cultivates, processes, produces, and manufactures medicinal and cannabis products. SEACH MEDICAL operates under Waste Management classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 73 people.
Foreign Associate
  USA
InstrumentIsrael Stock View All
ExchangeTel Aviv Stock Exchange
ISINIL0002490113
Business Address23 Paamei Aviv,
SectorIndustrials
IndustryWaste Management
BenchmarkDow Jones Industrial
Websitewww.seach.co.il
Phone972 9 770 0009
CurrencyILA
You should never invest in Seach Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Seach Stock, because this is throwing your money away. Analyzing the key information contained in Seach Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Seach Medical Key Financial Ratios

Seach Medical's financial ratios allow both analysts and investors to convert raw data from Seach Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Seach Medical over time and compare it to other companies across industries.

Seach Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Seach Medical's current stock value. Our valuation model uses many indicators to compare Seach Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seach Medical competition to find correlations between indicators driving Seach Medical's intrinsic value. More Info.
Seach Medical Group is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.85  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Seach Medical Group is roughly  1.17 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Seach Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Seach Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Seach Medical Group Systematic Risk

Seach Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Seach Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Seach Medical Group correlated with the market. If Beta is less than 0 Seach Medical generally moves in the opposite direction as compared to the market. If Seach Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Seach Medical Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Seach Medical is generally in the same direction as the market. If Beta > 1 Seach Medical moves generally in the same direction as, but more than the movement of the benchmark.

Seach Medical Thematic Clasifications

Seach Medical Group is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas

Seach Medical November 30, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Seach Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Seach Medical Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Seach Medical Group based on widely used predictive technical indicators. In general, we focus on analyzing Seach Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Seach Medical's daily price indicators and compare them against related drivers.

Complementary Tools for Seach Stock analysis

When running Seach Medical's price analysis, check to measure Seach Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seach Medical is operating at the current time. Most of Seach Medical's value examination focuses on studying past and present price action to predict the probability of Seach Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seach Medical's price. Additionally, you may evaluate how the addition of Seach Medical to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets